Neurologic and Psychiatric Manifestations of Bradykinin-Mediated Angioedema: Old and New Challenges

Neurologic and Psychiatric Manifestations of Bradykinin-Mediated Angioedema: Old and New Challenges

Neurologic manifestations have been occasionally described in patients with bradykinin-mediated angioedema. The existing literature is currently limited to case series and case reports mainly described in the hereditary forms (HAE) concerning central nervous system (CNS) involvement. On the contrary...

Full description

Bibliographic Details
Main Authors:	Ilaria Mormile, Francesco Palestra, Angelica Petraroli, Stefania Loffredo, Francesca Wanda Rossi, Giuseppe Spadaro, Amato de Paulis, Maria Bova
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	International Journal of Molecular Sciences
Subjects:	alteplase autonomic disfunction bradykinin central nervous system hereditary angioedema psychology
Online Access:	https://www.mdpi.com/1422-0067/24/15/12184

Similar Items

In Vitro Modeling of Bradykinin-Mediated Angioedema States
by: François Marceau, et al.
Published: (2020-08-01)

Bradykinin-induced angioedema in the emergency department
by: Jacques Hébert, et al.
Published: (2022-03-01)

Pediatric Angioedema without Wheals: How to Guide the Diagnosis
by: Lucia Liotti, et al.
Published: (2023-04-01)

Bradykinin Metabolism and Drug-Induced Angioedema
by: Sylwia Smolinska, et al.
Published: (2023-07-01)

Episodic Angioedema with Hypereosinophilia (Gleich’s Syndrome): A Case Report and Extensive Review of the Literature
by: Ilaria Mormile, et al.
Published: (2021-04-01)

The Role of Bradykinin Receptors in Hereditary Angioedema Due to C1-Inhibitor Deficiency
by: Wojciech Dyga, et al.
Published: (2022-09-01)

Could it be hereditary angioedema?—Perspectives from different medical specialties
by: Markus Magerl, et al.
Published: (2023-09-01)

Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
by: Stefan Hintze, et al.
Published: (2023-01-01)

Current and Future Therapy of Hereditary Angioedema
by: Öner Özdemir
Published: (2020-10-01)

The effect of estrogen-containing birth control pills on the constituents of bradykinin expression in plasma
by: Janette M. Birmingham, MS, et al.
Published: (2024-05-01)

The Role of Bradykinin Receptors in the Etiopathogenesis of Chronic Spontaneous Urticaria
by: Aleksander Obtulowicz, et al.
Published: (2021-10-01)

Clinical Characteristics and Management of Angioedema Attacks in Polish Adult Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency
by: Katarzyna Piotrowicz-Wójcik, et al.
Published: (2021-11-01)

Assessment of disease activity and quality of life in patients with recurrent bradykinin-mediated versus mast cell-mediated angioedema
by: Pelin Kuteyla Can, et al.
Published: (2021-07-01)

Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies
by: Emel Aygören-Pürsün, et al.
Published: (2018-05-01)

Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital
by: Pall AH, et al.
Published: (2020-07-01)

Oxidative stress markers in patients with hereditary angioedema
by: Stefano R. Del Giacco, et al.
Published: (2018-12-01)

Immunogenicity and Safety of Anti-SARS-CoV-2 mRNA Vaccines in a Cohort of Patients with Hereditary Angioedema
by: Ilaria Mormile, et al.
Published: (2023-01-01)

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
by: Werner Aberer, et al.
Published: (2017-07-01)

Hereditary Angioedema: Novel Molecules for Treatment of Acute Attacks and Long-Term Prophylaxis
by: Bianca Covella, et al.
Published: (2024-01-01)

Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study
by: Teresa Caballero, et al.
Published: (2018-03-01)

Bradykinin-Mediated Angioedema Induced by Commonly Used Cardiovascular Drugs
by: Janina Hahn, et al.
Published: (2023-09-01)

Hereditary angioedema due to C1 inhibitor deficiency: real-world experience from the Icatibant Outcome Survey in Spain
by: Mar Guilarte, et al.
Published: (2021-12-01)

Neprilysin Inhibitors and Bradykinin
by: Duncan J. Campbell, et al.
Published: (2018-09-01)

Abdominal and pelvic imaging in the diagnosis of acute abdominal attacks in patients with hereditary angioedema due to C1-inhibitor deficiency
by: Piotr Obtułowicz, et al.
Published: (2021-08-01)

Impaired Endothelial Function in Hereditary Angioedema During the Symptom-Free Period
by: Davide Firinu, et al.
Published: (2018-05-01)

The bradykinin-forming cascade in anaphylaxis and ACE-inhibitor induced angioedema/airway obstruction
by: Berhane Ghebrehiwet, et al.
Published: (2024-01-01)

Hereditary angioedema: a disease seldom diagnosed by pediatricians
by: Régis de Albuquerque Campos, et al.
Published: (2021-03-01)

Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency
by: Xavier Charest-Morin, et al.
Published: (2018-10-01)

Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
by: Marie Douillard, MD, et al.
Published: (2023-08-01)

Clinical profile of idiopathic angioedema based on severity and treatment response is independent of the presence of concomitant wheals
by: Reineke Soegiharto, et al.
Published: (2023-03-01)

Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants
by: François Marceau, et al.
Published: (2020-07-01)

An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension
by: Marc A. Riedl, et al.
Published: (2017-10-01)

Plasminflammation—An Emerging Pathway to Bradykinin Production
by: Coen Maas
Published: (2019-08-01)

Biochemistry, molecular genetics, and clinical aspects of hereditary angioedema with and without C1 inhibitor deficiency
by: Toshiyuki Miyata, et al.
Published: (2023-07-01)

Safety Aspects and Rational Use of Lanadelumab Injections in the Treatment of Hereditary Angioedema (HAE): Clinical Insights
by: Petkova E, et al.
Published: (2022-12-01)

The Search for Biomarkers in Hereditary Angioedema
by: Allen P. Kaplan, et al.
Published: (2017-11-01)

Angioedema and Fatty Acids
by: Akane Wada, et al.
Published: (2021-08-01)

The complex role of kininogens in hereditary angioedema
by: Allen P. Kaplan, et al.
Published: (2022-08-01)

Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks
by: Michihiro Hide, et al.
Published: (2021-01-01)

Commentary: Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics
by: Roger Colobran, et al.
Published: (2020-04-01)